https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
1% (2029 departments). The estimated numbers of patients with CCS, CEAS, and intestinal BD were 473 (95% confidence interval 357-589), 388 (289-486), and 3139 (2749-3529), respectively; the prevalence rates per 1,000,000 population were 3.7 (male 4.0; female 3.5), 3.1 (male 3.0; female 3.1), and 24.8 (male 24.5; female 25., respectively. The male-to-female ratios were 1.10, 0.94, and 0.93 for patients with CCS, CEAS, and intestinal BD, respectively. CONCLUSIONS Estimates of the national prevalence of CCS, CEAS, and intestinal BD i